← All candidates
5 insider filings on record.
5 filings on record.
INTSINTENSITY THERAPEUTICS, INC.
NasdaqCM · Healthcare · $11.22M
$4.15
+2.47% · Jul 31
5 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · dailyNo open-market activity in range
▸ hover a marker for the filing · drag to zoom
Reverse-split 1×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what INTS ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$11.22M
Float
2.5M
92% public
Short % float
Pro
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
Context
Wall St
$19.33 avg target
+365.9% vs today · 6 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Coverage
Intensity Therapeutics, Inc. Q2 2026 Earnings Call SummaryMoby · 08-12Intensity Therapeutics (INTS) Q2 2026 Earnings Call TranscriptMotley Fool · 08-12Intensity Therapeutics Inc. (INTS) Upgraded to Buy: Here's WhyZacks · 05-27Intensity Therapeutics Inc. (INTS) Could Find a Support Soon, Here's Why You Should Buy the Stock NowZacks · 05-01
The file stays open
5 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice